Cowen and Company’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-51,415
| Closed | -$2.6M | – | 640 |
|
|
2023
Q4 | $2.6M | Buy |
+51,415
| New | +$2.6M | 0.17% | 94 |
|
|
2022
Q2 | – | Sell |
-13,257
| Closed | -$491K | – | 595 |
|
|
2022
Q1 | $491K | Buy |
13,257
+5,527
| +72% | +$205K | 0.05% | 146 |
|
|
2021
Q4 | $235K | Sell |
7,730
-5,113
| -40% | -$155K | 0.02% | 257 |
|
|
2021
Q3 | $431K | Sell |
12,843
-14,865
| -54% | -$499K | 0.02% | 183 |
|
|
2021
Q2 | $1.11M | Buy |
27,708
+20,627
| +291% | +$823K | 0.06% | 112 |
|
|
2021
Q1 | $318K | Buy |
+7,081
| New | +$318K | 0.02% | 203 |
|
|
2020
Q4 | – | Sell |
-8,061
| Closed | -$382K | – | 289 |
|
|
2020
Q3 | $382K | Sell |
8,061
-13,733
| -63% | -$651K | 0.06% | 136 |
|
|
2020
Q2 | $1.29M | Buy |
21,794
+997
| +5% | +$58.8K | 0.21% | 70 |
|
|
2020
Q1 | $983K | Buy |
+20,797
| New | +$983K | 0.23% | 77 |
|